Semma Therapeutics adds Daniel Auerbach and Kevin Raidy to Board along with raising $114m Series B financing co-led by Eight Roads and Cowen Healthcare
– USA, MA – Semma Therapeutics, a biotechnology company focused on the development of novel regenerative medicines, announced today the successful completion of a highly oversubscribed $114 million Series B financing.…